findmyKOL

John Mulrow, MD

Basic profile

Urology San Antonio

ORCIDNone on fileNPI
RegionSan Antonio, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Mulrow is a Cardiology physician affiliated with Urology San Antonio. OpenAlex indexes 16 publications with 264 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

264citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4411 Medical Dr Ste 300
San Antonio, TX 782293824

Telephone

210-614-5400

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.9%
    Statin27.1%
    Atorvastatin Calcium65%Rosuvastatin Calcium20%Pravastatin Sodium8%Simvastatin4%Lovastatin1%Fluvastatin Sodium1%
    Part D<11 patients
    Beta blocker13.4%
    Metoprolol Succinate34%Carvedilol29%Metoprolol Tartrate27%Nebivolol Hcl7%Labetalol Hcl4%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    10.4%
    Factor Xa inhibitor5.6%
    Eliquis90%Xarelto10%
    Part D<11 patients
    P2Y12 inhibitor4.2%
    Clopidogrel100%
    Part D50 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    1.7%
    SGLT2 inhibitor1.1%
    Farxiga71%Jardiance30%
    Part D<11 patients
    Potassium supplement0.6%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)12.4% facility · 87.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”